BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 75 filers reported holding BRIDGEBIO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,753,687 | +39.1% | 749,097 | -9.3% | 0.00% | +100.0% |
Q2 2023 | $14,202,178 | -37.2% | 825,708 | -39.5% | 0.00% | -50.0% |
Q1 2023 | $22,632,646 | +251.2% | 1,365,057 | +61.4% | 0.00% | +100.0% |
Q4 2022 | $6,445,088 | +21.1% | 845,812 | +58.0% | 0.00% | 0.0% |
Q3 2022 | $5,322,000 | +4.7% | 535,329 | -4.4% | 0.00% | 0.0% |
Q2 2022 | $5,084,000 | -55.9% | 559,931 | -50.7% | 0.00% | 0.0% |
Q1 2022 | $11,531,000 | +10.9% | 1,136,071 | +82.2% | 0.00% | 0.0% |
Q4 2021 | $10,402,000 | -54.5% | 623,660 | +27.8% | 0.00% | -50.0% |
Q3 2021 | $22,875,000 | -30.8% | 488,044 | -10.0% | 0.00% | -33.3% |
Q2 2021 | $33,066,000 | +143.7% | 542,437 | +146.3% | 0.00% | +50.0% |
Q1 2021 | $13,569,000 | +114.3% | 220,270 | +147.3% | 0.00% | +100.0% |
Q4 2020 | $6,333,000 | +358.2% | 89,060 | +141.8% | 0.00% | – |
Q3 2020 | $1,382,000 | +91.9% | 36,828 | +66.8% | 0.00% | – |
Q2 2020 | $720,000 | +21.2% | 22,080 | +7.9% | 0.00% | – |
Q1 2020 | $594,000 | -57.6% | 20,459 | -48.8% | 0.00% | – |
Q4 2019 | $1,401,000 | +1247.1% | 39,953 | +720.9% | 0.00% | – |
Q3 2019 | $104,000 | – | 4,867 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |